http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-1016959-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fb3edb9a697ebfa78026d99c5a81b3c3
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J51-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J41-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J41-0072
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B05C19-02
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J51-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J41-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B05C19-02
filingDate 1963-04-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_be687e1431c51f263c56364d5c02dd60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e83c48eb2eb74a4d42e369de06b54893
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d2e6c536f22f2d0e461c216eb99c5bd6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_46640d5e16d9ee18aeab38cba9657447
publicationDate 1966-01-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber GB-1016959-A
titleOfInvention Substituted steroid hormones
abstract The invention comprises esters of various estrogenic, androgenic and corticoid steroid hormones and N,N-di-(b -haloethyl)-carbamic acids wherein the halogen is chlorine or bromine, and their preparation by (a) reacting either the corresponding steroid alcohol or an N,N-di-(b -haloethyl)-amine with carbonyl chloride or bromide to give the corresponding chloroformyl ester or amide and reacting this intermediate with the other starting material, or (b) esterifying a free hydroxyl group in a product of (a) with a pharmaceutically acceptable organic or inorganic acid. N - Chloroformyl - N,N - di - (b - chloroethyl) - amine is prepared by reaction of N,N-di-(b - chloroethyl)-amine with phosgene. The compounds of the invention have antitumou activity and may be used in combination with a pharmaceutical carrier in forms suitable for oral or parental administration, e.g. as tablets, capsules, solutions or suspensions.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0138153-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0138153-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004106358-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-2629657-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4082779-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4081461-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4332797-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4938897-A
priorityDate 1963-04-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397310
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559213
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6371
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID313
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID260
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID79057
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419556587
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559516
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66249
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419558836
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512559
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419501804
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24408

Total number of triples: 42.